Ovarian cancer accounts for 4% of all cancers in women and is the leading cause of death
from gynaecologic malignancies. Because early-stage ovarian cancer is generally …

▪ The pursuit of the ideal tumor marker has generated many tests for use in the diagnosis
and management of cancer, several of which are now widely available. Tumor markers have …

PURPOSE To produce definitions based on serial CA 125 levels to measure response of
ovarian carcinoma in patients receiving first-line chemotherapy. PATIENTS AND METHODS …

OBJECTIVES: MUC16 (CA125) protein is a high molecular weight mucin overexpressed in
the majority of epithelial ovarian cancers (EOC) but not in the epithelium of normal ovaries …

Objective: The aim of this study was to assess the complementary use of ultrasonographic
end points with the level of circulating CA 125 antigen by multivariate logistic regression …

Background: Epithelial ovarian cancer (EOC) cells are prone to metastasise throughout the
peritoneal cavity. The epithelial-to-mesenchymal transition (EMT) is a necessary step …

Serum concentrations of cancer antigen 125 (CA 125) were determined for 373 patients with
various liver diseases: 57 with acute hepatitis, 57 with chronic hepatitis, 244 with liver …

The pre-operative characterization of ovarian cysts remains a major challenge. Functional
cysts and some other benign cysts should be managed conservatively, whereas persistent …

Enriched tumor epithelium, tumor-associated stroma, and whole tissue were collected by
laser microdissection from thin sections across spatially separated levels of ten high-grade …

Background Platinum-based combination therapy is the standard first-line treatment for
women with advanced serous epithelial ovarian carcinoma (EOC). However, about 20% will …